Patent 7820685 was granted and assigned to Vertex Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.